Clinical Trial Update: Behavioral and Immunological Factors in Coronary Disease

View source ↗

Summary

The NHLBI-sponsored trial investigated behavioral and immunological factors in coronary disease, and the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Coronary Artery Disease
• Heart Disease
• Major Depressive Disorder

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Cardiovascular Diseases, Coronary Disease | Status: COMPLETED